Inhibrx Biosciences, Inc.INBXNASDAQ
LOADING
|||
PB Ratio: Premium Valuation
Trending lower, above historical average.
Left:
||||
Price-to-book ratio
Latest
1.67
↑ 186% above average
Average (8y)
-1.93
Historical baseline
Range
High:41.17
Low:-81.55
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 1.67 | -95.9% |
| 2023 | 41.17 | +141.8% |
| 2022 | 17.02 | -46.3% |
| 2021 | 31.69 | +187.2% |
| 2020 | 11.04 | +236.9% |
| 2019 | -8.06 | +16.8% |
| 2018 | -9.69 | +53.1% |
| 2017 | -20.64 | +74.7% |
| 2016 | -81.55 | - |